Bayesian clinical trials in action
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Although the frequentist paradigm has been the predominant approach to clinical trial design since the 1940s, it has several notable limitations. Advancements in computational algorithms and computer hardware have greatly enhanced the alternative Bayesian paradigm. Compared with its frequentist counterpart, the Bayesian framework has several unique advantages, and its incorporation into clinical trial design is occurring more frequently. Using an extensive literature review to assess how Bayesian methods are used in clinical trials, we find them most commonly used for dose finding, efficacy monitoring, toxicity monitoring, diagnosis/decision making, and studying pharmacokinetics/pharmacodynamics. The additional infrastructure required for implementing Bayesian methods in clinical trials may include specialized software programs to run the study design, simulation and analysis, and web‐based applications, all of which are particularly useful for timely data entry and analysis. Trial success requires not only the development of proper tools but also timely and accurate execution of data entry, quality control, adaptive randomization, and Bayesian computation. The relative merit of the Bayesian and frequentist approaches continues to be the subject of debate in statistics. However, more evidence can be found showing the convergence of the two camps, at least at the practical level. Ultimately, better clinical trial methods lead to more efficient designs, lower sample sizes, more accurate conclusions, and better outcomes for patients enrolled in the trials. Bayesian methods offer attractive alternatives for better trials. More Bayesian trials should be designed and conducted to refine the approach and demonstrate their real benefit in action. Copyright © 2012 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stochastic relaxation, gibbs distributions, and the bayesian restoration of images.
Geman, S., & Geman, D. (1984) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.1984.4767596 · Cited by 17,949 · cited 6×
“This two-centuryold stagnancy changed during the 1980s and the 1990s with the advent and development of the Markov Chain Monte Carlo (MCMC) [26, 27].”
BackgroundInfluentialSampling-based approaches to calculating marginal densities
Gelfand, A. E., & Smith, A. F. M. (1990) · Journal of the American Statistical Association · doi:10.1080/01621459.1990.10476213 · Cited by 6,606
Bernardo, J. M., & Smith, A. F. M. (1994) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316870 · Cited by 2,178
The BUGS project: evolution, critique and future directions
Lunn, D., Spiegelhalter, D., Thomas, A., & Best, N. (2009) · Statistics in Medicine · doi:10.1002/sim.3680 · Cited by 1,876
Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation
(1948) · BMJ · doi:10.1136/bmj.2.4582.769 · Cited by 986
Berger, J. O., & Wolpert, R. L. (1988) · doi:10.1214/lnms/1215466210 · Cited by 616
The interplay of Bayesian and frequentist analysis
Bayarri, M. J., & Berger, J. O. (2004) · Statistical Science · doi:10.1214/088342304000000116 · Cited by 525
Translation of Innovative Designs Into Phase I Trials
Rogatko, A., Schoeneck, D., Jonas, W., Tighiouart, M., Khuri, F. R., & Porter, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.1012 · Cited by 217
Bayesians, Frequentists, and Scientists
Efron, B. (2005) · Journal of the American Statistical Association · doi:10.1198/016214505000000033 · Cited by 201
Cited by
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials
Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081124 · Cited by 205
Bendtsen, M. (2018) · Journal of Medical Internet Research · doi:10.2196/10873 · Cited by 105
“While, compared with the NHST approach, the use of Bayesian methods to analyze randomized controlled trials is virtually nonexistent, it has increased over the past few years (Lee and Chu [24]).”
Methodthe Type 1 Diabetes TrialNet Study Group, Beam, C. A., MacCallum, C., Herold, K. C., Wherrett, D. K., Palmer, J., & Ludvigsson, J. (2017) · Diabetologia · doi:10.1007/s00125-016-4122-1 · Cited by 53
Current status of Bayesian clinical trials for oncology, 2020
Fors, M., & González, P. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100658 · Cited by 18
Metadata
- Authors
- Jack Lee, J., & Chu, C. T.
- Venue
- Statistics in Medicine
- Publisher
- Wiley
- Published
- 2012-06-18
- Volume
- 31
- Issue
- 25
- Pages
- 2955-2972
- ISSN
- 0277-6715 (ISSN-L)
- 1097-0258
- OpenAlex
- W2064117019
- Cited by
- 200
- References
- 9
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.